The ubiquitin ligase TRAF6 is a key regulator of canonical IkB kinase (IKK)/NF-kB signaling in response to interleukin-1 (IL-1) stimulation. Here, we identified the deubiquitinating enzyme YOD1 (OTUD2) as a novel interactor of TRAF6 in human cells. YOD1 binds to the C-terminal TRAF homology domain of TRAF6 that also serves as the interaction surface for the adaptor p62/Sequestosome-1, which is required for IL-1 signaling to NF-kB. We show that YOD1 competes with p62 for TRAF6 association and abolishes the sequestration of TRAF6 to cytosolic p62 aggregates by a non-catalytic mechanism. YOD1 associates with TRAF6 in unstimulated cells but is released upon IL-1b stimulation, thereby facilitating TRAF6 auto-ubiquitination as well as NEMO/IKKg substrate ubiquitination. Further, IL-1 triggered IKK/NF-kB signaling and induction of target genes is decreased by YOD1 overexpression and augmented after YOD1 depletion. Hence, our data define that YOD1 antagonizes TRAF6/p62-dependent IL-1 signaling to NF-kB.
Schimmack, G., Schorpp, K., Kutzner, K., Gehring, T., Brenke, J. K., Hadian, K., & Krappmann, D. (2017). YOD1/TRAF6 association balances p62-dependent IL-1 signaling to NF-κB. ELife, 6. https://doi.org/10.7554/eLife.22416